Log in
Enquire now
‌

US Patent 9107927 High-purity large-scale preparation of stannsoporfin

Patent 9107927 was granted and assigned to InfaCare Pharmaceutical on August, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
InfaCare Pharmaceutical
InfaCare Pharmaceutical
Current Assignee
InfaCare Pharmaceutical
InfaCare Pharmaceutical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9107927
Date of Patent
August 18, 2015
Patent Application Number
14460080
Date Filed
August 14, 2014
Patent Citations Received
‌
US Patent 12083145 Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
0
‌
US Patent 11878029 Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
0
Patent Primary Examiner
‌
Paul V Ward
Patent abstract

Large scale (bulk) compositions comprising high-purity stannsoporfin are disclosed, as well as methods of synthesizing such compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9107927 High-purity large-scale preparation of stannsoporfin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.